Literature DB >> 10594240

Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.

K Nelms1, T J O'Neill, S Li, S R Hubbard, T A Gustafson, W E Paul.   

Abstract

The SH2-B protein is an SH2-domain-containing molecule that interacts with a number of phosphorylated kinase and receptor molecules including the insulin receptor. Two isoforms of the SH2-B have been identified and have been proposed to arise through alternate splicing. Here we have identified a third isoform of the SH2-B protein, SH2-Bgamma, that interacts specifically with the insulin receptor. This interaction required phosphorylation of residue Y1146 in the triple tyrosine motif within the activation loop of the IR kinase and is one of only two signaling molecules shown to interact directly with this residue of the insulin receptor kinase domain. The intron/exon structure of the SH2-B gene was determined. Alternate splice sites utilized to generate the different isoforms of the SH2-B protein were identified in the 3' end of the SH2-B gene immediately downstream of the exon encoding the core of the SH2 domain. Additionally, the chromosomal location of the SH2-B gene was determined to be the distal arm of mouse Chromosome (Chr) 7 in a region linked to obesity in mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10594240     DOI: 10.1007/s003359901183

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  30 in total

1.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.

Authors:  Xiaocheng Dong; Sunmin Park; Xueying Lin; Kyle Copps; Xianjin Yi; Morris F White
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

3.  Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling.

Authors:  Minghua Li; Zhiqin Li; David L Morris; Liangyou Rui
Journal:  Endocrinology       Date:  2007-01-04       Impact factor: 4.736

4.  SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches.

Authors:  Chien-Jen Chen; Chien-Hung Shih; Yu-Jung Chang; Shao-Jing Hong; Tian-Neng Li; Lily Hui-Ching Wang; Linyi Chen
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

Review 5.  SH2B1 regulation of energy balance, body weight, and glucose metabolism.

Authors:  Liangyou Rui
Journal:  World J Diabetes       Date:  2014-08-15

6.  Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.

Authors:  Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-05-12

7.  Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation.

Authors:  Linyi Chen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Regulation of lifespan, metabolism, and stress responses by the Drosophila SH2B protein, Lnk.

Authors:  Cathy Slack; Christian Werz; Daniela Wieser; Nazif Alic; Andrea Foley; Hugo Stocker; Dominic J Withers; Janet M Thornton; Ernst Hafen; Linda Partridge
Journal:  PLoS Genet       Date:  2010-03-19       Impact factor: 5.917

9.  Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.

Authors:  Chaojun Duan; Hongyan Yang; Morris F White; Liangyou Rui
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins.

Authors:  David L Morris; Kae Won Cho; Yingjiang Zhou; Liangyou Rui
Journal:  Diabetes       Date:  2009-06-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.